Cite
Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers.
MLA
Wen, Tingyu, et al. “Development, Validation, and Evaluation of a Deep Learning Model to Screen Cyclin-Dependent Kinase 12 Inhibitors in Cancers.” European Journal of Medicinal Chemistry, vol. 250, Mar. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.115199.
APA
Wen, T., Wang, J., Lu, R., Tan, S., Li, P., Yao, X., Liu, H., Yi, Z., Li, L., Liu, S., Gao, P., Qian, H., Xie, G., & Ma, F. (2023). Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers. European Journal of Medicinal Chemistry, 250, N.PAG. https://doi.org/10.1016/j.ejmech.2023.115199
Chicago
Wen, Tingyu, Jun Wang, Ruiqiang Lu, Shuoyan Tan, Pengyong Li, Xiaojun Yao, Huanxiang Liu, et al. 2023. “Development, Validation, and Evaluation of a Deep Learning Model to Screen Cyclin-Dependent Kinase 12 Inhibitors in Cancers.” European Journal of Medicinal Chemistry 250 (March): N.PAG. doi:10.1016/j.ejmech.2023.115199.